NasdaqGS - Delayed Quote USD
Contineum Therapeutics, Inc. (CTNM)
At close: October 18 at 4:00 PM EDT
After hours: October 18 at 4:01 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
50,000.00
--
--
Operating Expense
38,619.00
33,923.00
22,720.00
28,647.00
Operating Income
-38,619.00
16,077.00
-22,720.00
-28,647.00
Net Non Operating Interest Income Expense
7,163.00
4,398.00
373.00
-255.00
Other Income Expense
-269.00
2,695.00
-1,906.00
-99.00
Pretax Income
-31,725.00
23,170.00
-24,253.00
-29,001.00
Tax Provision
-279.00
450.00
--
--
Net Income Common Stockholders
-227.00
22,720.00
-24,253.00
-29,001.00
Diluted NI Available to Com Stockholders
2,693.00
22,720.00
-24,253.00
-29,001.00
Basic EPS
-0.01
1.36
-1.45
-1.74
Diluted EPS
-0.01
1.12
-1.45
-1.74
Basic Average Shares
25,723.28
16,674.15
16,674.15
16,674.15
Diluted Average Shares
25,723.28
17,760.69
17,760.69
17,760.69
Total Operating Income as Reported
-38,619.00
16,077.00
-22,720.00
-28,647.00
Total Expenses
38,619.00
33,923.00
22,720.00
28,647.00
Net Income from Continuing & Discontinued Operation
-31,446.00
22,720.00
-24,253.00
-29,001.00
Normalized Income
-31,342.91
19,903.78
-22,439.00
-28,993.00
Interest Income
7,163.00
4,606.00
761.00
77.00
Interest Expense
--
208.00
388.00
332.00
Net Interest Income
7,163.00
4,398.00
373.00
-255.00
EBIT
-31,725.00
23,378.00
-23,865.00
-28,669.00
EBITDA
-31,524.00
23,573.00
-23,536.00
-28,344.00
Reconciled Depreciation
201.00
195.00
329.00
325.00
Net Income from Continuing Operation Net Minority Interest
-31,446.00
22,720.00
-24,253.00
-29,001.00
Total Unusual Items Excluding Goodwill
-104.00
2,872.00
-1,814.00
-8.00
Total Unusual Items
-104.00
2,872.00
-1,814.00
-8.00
Normalized EBITDA
-31,420.00
20,701.00
-21,722.00
-28,336.00
Tax Rate for Calcs
0.00
0.00
--
--
Tax Effect of Unusual Items
-0.91
55.78
--
--
12/31/2021 - 4/5/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BOLD Boundless Bio, Inc.
3.0500
+0.66%
ULTI.OL Ultimovacs ASA
1.8200
+1.79%
ANRO Alto Neuroscience, Inc.
14.43
+1.12%
MBX MBX Biosciences, Inc.
24.07
+3.93%
CRGX CARGO Therapeutics, Inc.
22.22
+2.40%
THRD Third Harmonic Bio, Inc.
13.46
+2.67%
BCAX Bicara Therapeutics Inc.
21.96
+7.44%
BGBIO.OL BerGenBio ASA
8.98
-0.19%
LENZ LENZ Therapeutics, Inc.
27.99
+6.34%
CNTX Context Therapeutics Inc.
2.0400
+1.49%